Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases
View Patent ↗To provide a therapeutic agent and a diagnostic agent for mitochondrial dysfunction brain diseases including cerebral infarction as a representative. A therapeutic agent for a mitochondrial dysfunction brain disease, which comprises (A) δ-aminolevulinic acid represented by the formula (1), a derivative thereof, or a salt thereof and (B) an iron compound in combination. R 2 R 1 NCH 2 COCH 2 CH 2 COR 3 (1) wherein R 1 and R 2 each independently represents a hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group, an aryl group, or an aralkyl group; and R 3 represents a hydroxy group, an alkoxy group, an acyloxy group, an alkoxycarbonyloxy group, an aryloxy group, an aralkyloxy group, or an amino group.
1. A method for treating a mitochondrial dysfunction brain disease selected from the group consisting of Parkinson's Disease, Alzheimer's Disease, atherothrombotic cerebral infarction, cerebral ischemia at surgery and intravascular surgery, comprising administering to a subject, an effective amount of a therapeutic agent which comprises:
(A) a δ-aminolevulinic acid represented by the formula (1), a derivative thereof, or a salt thereof:
R 2 R 1 NCH 2 COCH 2 CH 2 COR 3 (1)
wherein R 1 and R 2 each independently represents a hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group, an aryl group, or an aralkyl group; and R 3 represents a hydroxy group, an alkoxy group, an acyloxy group, an alkoxycarbonyloxy group, an aryloxy group, an aralkyloxy group, or an amino group, and (B) an iron compound.
2. The method according to claim 1 , wherein (B) the iron compound is one or two or more compounds selected from ferric chloride, iron sesquioxide, iron chlorophyllin sodium, ferritin iron, ferrous citrate, sodium iron citrate, ammonium iron citrate, ferrous fumarate, ferrous pyrophosphate, ferric pyrophosphate, saccharated iron oxide, iron acetate, iron oxalate, ferrous succinate, sodium iron succinate citrate, heme iron, dextran iron, iron lactate, ferrous gluconate, sodium iron diethylenetriaminepentaacetate, ammonium iron diethylenetriaminepentaacetate, sodium iron diethylenediaminetetraacetate, ammonium iron diethylenediaminetetraacetate, triethylenetetramine iron, sodium iron dicarboxymethylglutamate, ammonium iron dicarboxymethylglutamate, choline iron citrate, ferrous formate, ferric formate, ammonium ferric potassium oxalate, ferrous sulfate, ferric sulfate, ammonium iron sulfate, ferric carbonate, ferrous chloride, and iron oxide.
3. A diagnostic method for a mitochondrial dysfunction brain disease selected from the group consisting of Parkinson's Disease, Alzheimer's Disease, atherothrombotic cerebral infarction, cerebral ischemia and intravascular surgery, which comprises:
administering a δ-aminolevulinic acid represented by the formula (1), a derivative thereof, or a salt thereof:
R 2 R 1 NCH 2 COCH 2 CH 2 COR 3 (1)
wherein R 1 and R 2 each independently represents a hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group, an aryl group, or an aralkyl group; and R 3 represents a hydroxy group, an alkoxy group, an acyloxy group, an alkoxycarbonyloxy group, an aryloxy group, an aralkyloxy group, or an amino group.